Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

The Effect of Betahistine on Body Weight in Obese Subjects

ClinicalTrials.gov ID: NCT00409305

Public ClinicalTrials.gov record NCT00409305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 6:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to examine the effect that betahistine has on body weight in obese subjects.

Study identification

NCT ID
NCT00409305
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
OBEcure Ltd.
Industry
Enrollment
280 participants

Conditions and interventions

Conditions

Interventions

Drug · Behavioral

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2007 (Type not available)
Primary completion
Not listed
Completion
Jun 2007 (Actual)
Last update posted
Apr 21, 2015

2007

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
Cahaba Research, Inc. Birmingham Alabama 35242 —
Scripps Clinic, Nutrition Metabolic Research San Diego California 92130 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Miami Research Associates, Inc., Nutrition Division Miami Florida 33143 —
CSRA Partners in Health, Inc. Augusta Georgia 30909 —
Radiant Research, Inc. Chicago Illinois 60610 —
NCCR Chicago Illinois 60611 —
American Health Network Indianapolis Indiana 46254 —
Midwest Institute for Clinical Research Indianapolis Indiana 46260 —
Radiant Research, Inc. Overland Park Kansas 66215 —
L-MARC Research Center Louisville Kentucky 40213 —
Pennington Biomedical Research Center Baton Rouge Louisiana 70808 —
Radiant Research, Inc. Edina Minnesota 55435 —
Diabetes & Endocrinology Specialists Chesterfield Missouri 63017 —
Comprehensive Weight Control Program New York New York 10021 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
Lindner Clinical Trial Center Cincinnati Ohio 45219 —
Covance CRU, Inc. Portland Oregon 97239 —
Diabetes & Glandular Disease Research Associates, Inc. San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00409305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2015 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00409305 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →